国家: 台湾
语言: 中文
来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
HUMAN ALBUMIN
傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487)
B05AA01
注射液劑
HUMAN ALBUMIN (1600000150) (human plasma protein with at least 95% albumin)G/L
玻璃小瓶裝
菌 疫
限由醫師使用
CSL BEHRING L.L.C. ROUTE 50 NORTH, 1201 N. KINZIE, BRADLEY, IL 60915, USA US
albumin
低蛋白血症、休克、燒傷。
有效日期: 2029/08/12; 英文品名: AlbuRx TM 25
2014-08-12
Sodium N- acetyltryptophanate 20 mmol/l Sodium caprylate 20 mmol/l Sodium chloride 140 mmol/l 1 250/95 AlbuRx 25 AlbuRx 25 AlbuRx 253.2(140 mmol/l) / (Paediatric population) (0-18) 1 2 3 4 5 AlbuRx 25 5 0.9 1-2/ “ ” 25% ALBURX™ 25 000960 hemorrhagic diathesis anuria 250 / 4 200-250 / 40-50 / AlbuRx 253.2(140 mmol/l) AlbuRx 25 AlbuRx 25 AlbuRx 25 ATCB05AA01 50 10 4-5 / 40 - 4555-60 19 2 10 AlbuRx 25 3 AlbuRx 25 EXP AlbuRx 25 30°C AlbuRx 25 5 0.9 AlbuRx 25Type II 12.5 / 50 25 / 100 CSL Behring AG Wankdorfstrasse 10, 3014 Bern, Switzerland CSL Behring LLC Route 50 North, 1201N. Kinzie, Bradley, IL 60915, USA (02) 2361-30400800-231956 201612 AlbuRx ® CSL Behring AG A. B. Packmittel-Bezeichung/ Packaging material Satzanweisung-Nr./ Drawing no. Print Services Entwicklung und Grafik Graphic arts and typesetting Packungsbeilage / package insert Format 600 x 270 mm 600 x 270 mm Maßstab/Scale 1:1 Gezeichnet/Drawn by E. Baum Ausgabe-Datum/Date of edition 22.08.2012 gem. PM-Blatt Ausgabe 500 10 5 5 5 5 0 9 270 10 Code 30 1 r e b m u n e d o c g n i g a k c a p / r e m m u n l e t t i m k c a P COMPOSITION _A. ACTIVE SUBSTANCE_ Human albumin _B. EXCIPIENTS_ Sodium N-acetyltryptophanate 20 mmol/l Sodium caprylate 20 mmol/l Sodium chloride q.s. to a sodium content of 140 mmol/l Water for injections q.s. to 1 l PHARMACEUTICAL FORM AND ACTIVE SUBSTANCE CONTENT PER UNIT Solution for infusion for intravenous use. The solution contains 250 g/l of human plasma protein, of which at least 95% is human albumin. AlbuRx 25 is an almost colourless, yellow, amber, or green solution for infusion. AlbuRx 25 is hyperoncotic to normal plasma. AlbuRx 25 contains approximately 3.2 mg sodium per ml of solution (140 mmol/l). THERAPEUTIC INDICATIONS Hypoproteinemia, shock, burns. DESCRIPTION Restoration and maintenance of circulating blood volume in cases of volume deficiency where the use of a colloid is indicated. The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on 阅读完整的文件